Contact Us
Contact Us
Home Finance Moleculin Biotech receives Nasdaq delisting notice after minimum bid price violation
Finance

Moleculin Biotech receives Nasdaq delisting notice after minimum bid price violation

September 18, 20261 Mins read0
Share
Moleculin Biotech receives Nasdaq delisting notice after minimum bid price violation
Share


Moleculin Biotech receives Nasdaq delisting notice after minimum bid price violation

Source link

Share
US and Denmark near deal on expanded military presence in Greenland – report Previous post US and Denmark near deal on expanded military presence in Greenland - report

Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Articles
Revolution Medicines COO Margaret Horn sells 9,612 of common stock
Finance

Revolution Medicines COO Margaret Horn sells $989,612 of common stock

BySeptember 18, 2026
Moleculin Biotech receives Nasdaq delisting notice after minimum bid price violation
Finance

Synaptics VP & corporate controller Esther Song sells $5,835 in stock

BySeptember 18, 2026
Daktronics increases CFO salary and reports results of annual shareholder meeting
Finance

Daktronics increases CFO salary and reports results of annual shareholder meeting

BySeptember 18, 2026
Oracle’s billion data center debt under pressure, FT reports
Finance

Oracle’s $18 billion data center debt under pressure, FT reports

BySeptember 18, 2026
© Copyright 2024 Jellywp. All rights reserved powered by Jellywp.com